Theme Parks and Crowd Handling May Never Be the Same After the COVID-19 Pandemic

 

 

The COVID-19 pandemic makes us look at each other differently; we keep our distance, suspicious of whether others are contagious or not, isolated and atomized in our work and social lives. How will this affect our behavior after COVID-19 has come and gone?

There are two theories: We might get over it and continue our lives as we did before, or, as many scientists predict, we may change our behavior permanently and become more cautious about infections. This psychological imprint could have drastic effects on business, including the theme park and attractions industry. Theme parks are known as crowded places, packed with people every weekend, with queue lines being some of the most prolonged human-to-human contact at a park.

To get a better understanding for how these common park dynamics are being viewed through a more critical lens, Voice of B2B Daniel Litwin sat down with Peter Rødbro, CEO of The Experience Ticket, to get his take on the future of crowd management in public spaces such as theme parks.

Do guests really want to stay in queue lines after COVID-19, or will they be reluctant to do so and prefer to go to theme parks without lines, or avoid them all together? Rødbro mentioned research that has shown waiting in queues was already a top guest complaint, and until now, somehow the parks could get away with it as a kind of fact of life. Pressing health and hygienic awareness, though, could be the tipping point where crowded queues are simply no longer socially acceptable.

How would a theme park with no queue lines operate? Would this affect the business model? Does this impact the daily capacity? And what digital infrastructure is needed to pull off such a major shift? Rødbro and the team at The Experience Ticket share their research and industry experience.

For the latest news, videos, and podcasts in the Sports & Entertainment Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Agentic AI
Agentic AI: IBM is Powering the Next Wave of Autonomous, Intelligent Decision-Making
March 14, 2025

Retail has long embraced automation, but now it’s taking a leap into a new frontier—autonomous decision-making. Enter agentic AI, a technology that doesn’t just automate tasks but makes real-time, intelligent decisions. With major retailers like Walmart integrating AI-driven fulfillment robots and brands such as Bath & Body Works rolling out personalized AI-powered shopping assistants,…

Read More
QSR connectivity
How IBM and Hughes Are Powering the Future of QSR Connectivity & Fast Food Tech
March 14, 2025

Quick service restaurants (QSRs) are under increasing pressure to enhance speed, efficiency, and customer experience—all while managing a growing network of digital systems. From AI-powered ordering kiosks to real-time kitchen automation, modern QSRs are more connected than ever. The restaurant AI market was valued at $9.68 billion in 2024, and expected to reach $49 billion…

Read More
Trade tariffs
From Asia to the World: How Dimerco is Helping Businesses Navigate New Trade Tariffs and Supply Chain Shifts
March 13, 2025

The global supply chain is once again at a crossroads, with shifting trade policies, geopolitical tensions, and economic fluctuations shaping the way goods move across the world. The looming threat of new trade tariffs on imports from Asia, combined with fluctuating shipping rates, is creating a challenging landscape for logistics professionals. With businesses re-evaluating…

Read More
sterile compounding
Sterile Compounding and Contamination Control with Abby Roth
March 11, 2025

In this episode of Exceeding Your Benchmark, host Michelle Dawn Mooney speaks with Abby Roth, founder of Pure Microbiology, about sterile compounding and contamination control. Abby shares her expertise in microbiology, sterile environments, and best practices in pharmaceutical compounding. The conversation begins with a distinction between traditional drug manufacturing and sterile compounding, highlighting the…

Read More